Article written by: Joe Barber

Pfizer has announced that it plans to increase the list price of 41 medicines, or 10 percent of its entire drug portfolio, as of January 15. The company indicated that “the increase in list price to this subset of [our] portfolio will be 5 percent,” with the only exceptions being three drugs, which will see their prices rise 3 percent, and one other product, whose cost will jump 9 percent. List prices for the remainder of the portfolio will be unchanged, the drugmaker said.

Read full article here: